上海上美化妆品股份有限公司(02145.HK)今日盘中股价大涨5.01%,引发市场广泛关注。
盘面上,主因可能与公司布局重组胶原蛋白赛道密切相关。近日,上美股份与专注重组胶原蛋白领域的江苏聚源生物技术有限公司成立合资公司江苏聚源上美生物科技有限公司,正式进军重组胶原蛋白领域。重组胶原蛋白被视为美妆行业新热门材料,未来市场前景广阔。数据显示,预计到2027年重组胶原蛋白市场规模将达到1083亿元。上美股份的这一举措顺应了行业发展趋势,有望为公司带来新的增长点。
除此之外,上美股份近期在基因工程、再生医学等领域也有多项投资布局,显示公司正加大创新研发力度,未来或将推出更多创新产品。另外,南向资金连续3天增持该股,或为股价带来利好提振。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.